粤万年青：预计2025年度归母净利润亏损200万元-400万元

Core Viewpoint - The company expects a net profit loss attributable to shareholders of 2 to 4 million yuan in 2025, compared to a profit of 4.1627 million yuan in the same period last year [1] Group 1: Financial Performance - The primary reason for the performance change is that the newly expanded health consumer products and medical health business segments are still in the market cultivation phase, leading to high fixed cost allocation and a temporary impact on overall profits [1] - The company estimates that non-recurring gains and losses will impact net profit by approximately 13 to 16 million yuan during the reporting period [1]